Dudekula, Noor; Arora, Vikas; Callaerts-Vegh, Zsuzsanna; Bond, Richard A.
July 2005
Dose-Response;2005, Vol. 3 Issue 3, p414
Academic Journal
Recent publications in the field of asthma therapeutics and studies performed over the last decade in the treatment of chronic heart failure suggest a phenomenon called 'temporal hormesis'. This phenomenon can be defined as the beneficial action of drug after chronic administration as opposed to its detrimental acute effects. Temporal hormesis may be related to the classification of the drug molecule as an agonist, antagonist or an inverse agonist. This phenomenon may be a more general principal applicable in the treatment of other diseases apart from asthma and chronic heart failure.


Related Articles

  • Putting a block on heart failure deaths. Ahmed, Mohammed // GP: General Practitioner;6/3/2002, p70 

    Focuses on the benefits of beta-blockers in treating heart failure. Improvement of left ventricular functions; Performance of clinical trials on the effects of carvedilol; Reduction of mortality.

  • Two beta blockers: two difference effects on CHF.  // Medical Marketing & Media;Jul2001, Vol. 36 Issue 7, p26 

    Examines the effects of beta blockers on chronic heart failure. Reduction on the risk of death; Decrease of hospitalization costs; Distributor of bucindol drugs.

  • Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Maggioni, A.P.; Sinagra, G.; Opasich, C.; Geraci, E.; Gorini, M.; Gronda, E.; Lucci, D.; Tognoni, G.; Balli, E.; Tavazzi, L. // Heart;Mar2003, Vol. 89 Issue 3, p299 

    Background: Several large controlled trials have shown that β blockers given to patients with heart failure (New York Heart Association functional class II-IV) reduce morbidity and mortality. Despite these impressive results, implementing the use of β blockade in clinical practice appears...

  • Obstacles to the initiation of β blockers for heart failure in a specialised clinic within a district general hospital. Mahmoudi, M.; McDonagh, S.; Poole-Wilson, P.A.; Dubrey, S.W. // Heart;Apr2003, Vol. 89 Issue 4, p442 

    Examines the obstacles to the initiation of beta blockers for heart failure in a specialized clinic within a district general hospital. Data showing that beta blocker therapy should be used regardless of age, presence of diabetes, renal impairment or concomitant therapy with digitalis,...

  • Beta-Blocker Therapy for Chronic Heart Failure. Carter, Chuck // American Family Physician;4/15/2003, Vol. 67 Issue 8, p1793 

    Discusses the study 'Î’-Blockers in Chronic Heart Failure: Considerations for Selecting an Agent,' by M.L. Kukin, from the November 2002 issue of the journal 'Mayo Clinic Proceedings.'

  • Survival of patients aged >70 years on beta blockers.  // Age & Ageing;Sep2009, Vol. 38 Issue 5, p501 

    The article reports on the results of a trial of 272 patients over the age of 70 years with heart failure who were either treated or left untreated with a beta-blocking agent.

  • Are we oversubscribing â blockers for heart disease?  // BMJ: British Medical Journal;10/6/2012, Vol. 345 Issue 7877, p13 

    The article reports a study in the October 2012 issue of "The Journal of the American Medical Association," which found that the use of β blockers is not as useful as once believed for cardiovascular risk except for heart failure or as secondary prevention after a recent myocardial infarction...

  • Q/What is the best beta-blocker for systolic heart failure? Hulkower, Stephen; Aiken, Benjamin A.; Stigleman, Sue // Journal of Family Practice;Feb2015, Vol. 64 Issue 2, p122 

    The article provides an answer to a question of the best beta-blocker for systolic heart failure.

  • Registry to track beta-blocker users.  // Patient Care;12/15/1998, Vol. 32 Issue 20, p14 

    Reports on the Coreg Heart Failure Registry's (COHERE) probe into heart failure patients taking the drug carvedilol in North America. Data on the use of beta-blockade with the drug in a patient population; Aims of the COHERE program.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics